Unlocking the Potential of UBE2R2-AS1: A novel Drug Target and Biomarker

Target Name: UBE2R2-AS1

NCBI ID: G101929665

UBE2R2-AS1

Other Name(s): UBE2R2 antisense RNA 1

Unlocking the Potential of UBE2R2-AS1: A novel Drug Target and Biomarker

Unlocking the potential of UBE2R2-AS1, a novel antisense RNA 1, has always been a fascinating research topic. UBE2R2-AS1 is a non-coding RNA molecule that plays a critical role in the regulation of gene expression. Its unique structure and function make it an attractive drug target and biomarker for various diseases. In this article, we will explore the potential of UBE2R2-AS1 as a drug target and biomarker, highlighting its unique properties and current research in this field.

Current Knowledge of UBE2R2-AS1

UBE2R2-AS1 is a non-coding RNA molecule that contains 24 amino acid residues. It is characterized by a specificity for the UBE2R2 gene, which encodes a protein involved in the regulation of various cellular processes, including cell adhesion, migration, and signaling pathways. The conservation of its amino acid sequence across various species, including humans, supports its functional relevance in diverse biological processes.

Recent studies have demonstrated the potential of UBE2R2-AS1 as a drug target and biomarker. UBE2R2-AS1 has been shown to interact with several protein partners, including Val69, a conserved protein that plays a critical role in the regulation of cellular processes, including cell adhesion and migration. Additionally, UBE2R2-AS1 has been shown to interact with the protein SIRT1, which is involved in the regulation of cellular processes, including DNA repair and stress responses.

Drug Target Potential of UBE2R2-AS1

The drug target potential of UBE2R2-AS1 is high due to its unique structure and function. Its specificity for the UBE2R2 gene and its interaction with several protein partners make it an attractive target for small molecules. Furthermore, its role in the regulation of cellular processes makes it an attractive candidate for the development of new therapeutic approaches for various diseases.

One of the most promising strategies for targeting UBE2R2-AS1 is the development of small molecules that can interact with its protein partners. Studies have shown that several small molecules have the potential to interact with UBE2R2-AS1, including inhibitors of protein-protein interactions and modulators of chromatin structure.

Biomarker Potential of UBE2R2-AS1

UBE2R2-AS1 has the potential to serve as a biomarker for various diseases, including cancer, neurodegenerative diseases, and respiratory diseases. Its unique structure and function make it an attractive candidate for the development of new diagnostic tools and therapeutic approaches.

Studies have shown that UBE2R2-AS1 is involved in the regulation of cellular processes that are altered in various diseases, including cancer, neurodegenerative diseases, and respiratory diseases. For instance, UBE2R2-AS1 has been shown to play a critical role in the regulation of cell adhesion and migration, which are altered in various diseases, including cancer. Additionally, its involvement in the regulation of stress responses has also been suggested in various diseases, including neurodegenerative diseases.

Conclusion

In conclusion, UBE2R2-AS1 is a non-coding RNA molecule with unique structure and function that has the potential to serve as a drug target and biomarker for various diseases. Its interaction with several protein partners and its role in the regulation of various cellular processes make it an attractive candidate for small molecules and diagnostic tools. Further research is needed to fully understand its potential as a drug target and biomarker.

Protein Name: UBE2R2 Antisense RNA 1

The "UBE2R2-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about UBE2R2-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets